Key statistics
On Wednesday, Hansa Biopharma AB (HNSA:STO) closed at 42.50, -25.83% below its 52-week high of 57.30, set on Aug 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.38 |
---|---|
High | 42.96 |
Low | 41.92 |
Bid | 42.50 |
Offer | 42.50 |
Previous close | 42.84 |
Average volume | 112.80k |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.91bn SEK |
EPS (TTM) | -14.59 SEK |
Data delayed at least 15 minutes, as of Sep 18 2024 17:00 BST.
More ▼
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
- Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update
- Hansa Biopharma to host Q2 2024 interim results conference call
- Hansa Biopharma: increase in number of shares and votes
More ▼